IL-6 level in astrocytic-derived EVs in the central nervous system of ALS patients gradually increases with the development of the disease, indicating its potentiality in being a biological marker for the disease (Chen Y. et al., 2019). Here, IL6 is linked to amyotrophic lateral sclerosis.